Tag
While many studies have shown these medications help treat AS symptoms, more research has been needed about their impact on long-term disease progression.
‘I’ve got no idea how to use pain scales to record different kinds of pain … from different sources … and at different times and intensities.’
‘Identification, evaluation, and management of enthesitis is critical to ameliorate the overall burden of disease,’ according to researchers.
“An improved risk stratification and vigilance for early diagnosis and treatment of AS particularly in African American patients is needed,” say study authors.
Cosentyx is the second interleukin-17 drug approved for non-radiographic axial spondyloarthritis, which is adding to treatment options for patients with this type of inflammatory arthritis.
This research confirms the important role of high-intensity exercise in the treatment of axSpA, say study authors.
Could pain symptoms be improved in researchers assess patients’ pain perception as part of their treatment plan?
In a new study, hardly anyone who had nr-axSpA at baseline developed spinal damage within two years.
Taltz, approved last year for ankylosing spondylitis, inhibits an immune system protein called IL-17 that can lead to inflammation.
By CreakyStaff
Eleven percent of fibro patients in a new study reported having all of the symptoms consistent with patient-reported versions of a set of common criteria for axial spondyloarthritis.
By 
By 
